Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06297161 · ClinicalTrials.gov registry record
A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).
A clinical trial of Chronic Leukemia Myelogenous, sponsored by Pfizer.
- Active
- Registry status
- 600
- Enrollment target
- 1
- Study location
NCT06297161 is a study of Chronic Leukemia Myelogenous that is active but no longer recruiting, run by Pfizer. The registered enrollment target is 600 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06297161, a study of Chronic Leukemia Myelogenous, is active but no longer recruiting, sponsored by Pfizer.
- ACTIVE NOT RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to look at how safe and effective is bosulif in routine clinical practice. This study is seeking for participants who are: * Adult Patients who are just confirmed to have Chronic Myeloid Leukemia (CML) defined in Local Product Document (LPD). CML is a type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood. LPD explains what a medicine's benefits and problems are. LPD also explains how to use the medicine correctly in Korea. * willing to take part in the study after being informed about the study. All participants in this study will receive bosulif. All participants who have entered this study should meet the usual prescribing criteria for bosulif as per the LPD. The participants will be treated with bosulif under routine clinical practice in Korea. The study will look at the experiences of people receiving the study medicine. This will help to see if the study medicine is safe and effective. In this study all treatment and checking of the patients will be done as per the study doctor. The study can be performed in Korean health care centers where bosulif is prescribed to treat CML after the patients have agreed to take part in the study.
Conditions Studied
Interventions
- DRUG Bosulif
Study Locations (1)
New York
- Pfizer New York - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2025-01-20 |
| Est. Completion | 2028-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06297161
The ClinicalTrials.gov registry entry for NCT06297161 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Leukemia Myelogenous appearing as the primary indexed condition, and to 1 intervention - of which Bosulif is the first listed.
NCT06297161 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06297161 about?
NCT06297161 is a clinical study titled "A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).". The purpose of this study is to look at how safe and effective is bosulif in routine clinical practice. This study is seeking for participants who are: * Adult Patients who are just confirmed to have Chronic Myeloid Leukemia (CML) defined in Local Product Document (LPD). CML is a type of cancer th...
What is the current status of trial NCT06297161?
This trial is currently active not recruiting. The enrollment target is 600 participants. The study started on 2025-01-20. Estimated completion is 2028-06-01.
What conditions does trial NCT06297161 study?
This clinical trial studies the following conditions: Chronic Leukemia Myelogenous.
What interventions are being tested in trial NCT06297161?
The interventions under investigation include: Bosulif (DRUG).
Who is sponsoring clinical trial NCT06297161?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06297161 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.